The cross-platform shell that nobody expected to take seriously.
California biotech Kali Therapeutics has snagged its first major pharma partner, Sanofi, which is committing $180 million in near-term payments for rights to a T-cell engager (TCE) for autoimmune ...
A new malware family named 'AgingFly' has been identified in attacks against local governments and hospitals that steal ...